Perrigo OTC Growth Rides Innovation Path Wider Than Switches

When Perrigo executives confirmed their faith during an earnings briefing in the firm's OTC private label as its primary revenue driver, some analysts wanted more as assurance that the business will continue stabilizing the firm.